Vol. 25 No. 2 (2021)
REVIEWS

Edge-to-edge mitral valve repair in the surgical treatment of hypertrophic cardiomyopathy

PDF (Русский)
  • S.A. Budagaev,
  • A.V. Afanasyev,
  • A.V. Bogachev-Prokophiev,
  • M.A. Ovchinnikova,
  • A.N. Pivkin,
  • D.A. Astapov,
  • I.I. Demin
S.A. Budagaev
Meshalkin National Medical Research Center, Novosibirsk
Bio
A.V. Afanasyev
Meshalkin National Medical Research Center, Novosibirsk
A.V. Bogachev-Prokophiev
Meshalkin National Medical Research Center, Novosibirsk
M.A. Ovchinnikova
Meshalkin National Medical Research Center, Novosibirsk
A.N. Pivkin
Meshalkin National Medical Research Center, Novosibirsk
D.A. Astapov
Meshalkin National Medical Research Center, Novosibirsk
I.I. Demin
Meshalkin National Medical Research Center, Novosibirsk
DOI: https://doi.org/10.21688/1681-3472-2021-2-19-26

Published 2021-06-28

Keywords

  • edge-to-edge technique,
  • hypertrophic cardiomyopathy,
  • mitral valve repair,
  • septal myectomy

How to Cite

Budagaev, S., Afanasyev, A., Bogachev-Prokophiev, A., Ovchinnikova, M., Pivkin, A., Astapov, D., & Demin, I. (2021). Edge-to-edge mitral valve repair in the surgical treatment of hypertrophic cardiomyopathy. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 25(2), 19–26. https://doi.org/10.21688/1681-3472-2021-2-19-26

Copyright (c) 2021 Budagaev S.A., Afanasyev A.V., Bogachev-Prokophiev A.V., Ovchinnikova M.A., Pivkin A.N., Astapov D.A., Demin I.I.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Septal myectomy is the method of choice for treating symptomatic left ventricular outlet obstruction in patients with hypertrophic cardiomyopathy who are resistant to drug therapy. An important role in persistence, residual obstruction, mitral valve abnormalities and anterior systolic mitral valve movement is systolic anterior motion. Several authors have reported the use of edge-to-edge mitral valve repair in addition to septal myectomy in patients with mild septal hypertrophy. We performed a literature review on the surgical treatment of obstructive hypertrophic cardiomyopathy—mitral valve repair using the edge-to-edge technique with septal myectomy. Four retrospective studies and three clinical cases were analysed. The data of patients who underwent mitral valve repair surgery using the edge-to-edge technique with septal myectomy and had satisfactory long-term clinical and hemodynamic results were studied. This treatment technique should be considered in cases of unexpressed hypertrophy when isolated limited myectomy is insufficient to eliminate the left ventricular outlet or when there is a hemodynamically significant mitral insufficiency caused by anterior systolic movement of the mitral valve that increases the need for intervention on interventricular hypertrophy of the associated disease. Septal defect, plastic mitral valve, surgically significant residual mitral regurgitation and high residual left ventricular outflow gradients in long-term follow-up are feasible, safe and effective for anterior systolic mitral valve movement.

Received 28 September 2020. Revised 23 March 2021. Accepted 25 March 2021.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

Author contributions
Conception and study design: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev
Data collection and analysis: S.A. Budagaev, M.A. Ovchinnikova, A.N. Pivkin, I.I. Demin
Drafting the article: S.A. Budagaev, A.V. Afanasyev
Critical revision of the article: A.V. Bogachev-Prokophiev, D.A. Astapov
Final approval of the version to be published: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev, M.A. Ovchinnikova, A.N. Pivkin, D.A. Astapov, I.I. Demin

PDF (Русский)

References

  1. Maron B.J. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med. 2018;379(7):655-668. PMID: 30110588. https://doi.org/10.1056/NEJMra1710575
  2. Pellicca F., Alfieri O., Calabrò P., Cecchi F., Ferrazzi P., Gragnano F., Kaski J.P., Limongelli G., Maron M., Rapezzi C., Seggewiss H., Yacoub M.H., Olivotto I. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team. Int J Cardiol. 2020;304:86-92. PMID: 31983465. https://doi.org/10.1016/j.ijcard.2020.01.021
  3. Yu E.H., Omran A.S., Wigle E.D., Williams W.G., Siu S.C., Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol. 2000;36(7):2219-2225. PMID: 11127464. https://doi.org/10.1016/s0735-1097(00)01019-6
  4. Balaram S.K., Ross R.E., Sherrid M.V., Schwartz G.S., Hillel Z., Winson G., Swistel D.G. Role of mitral valve plication in the surgical management of hypertrophic cardiomyopathy. Ann Thorac Surg. 2012;94(6):1990-1997. PMID: 22858269. https://doi.org/10.1016/j.athoracsur.2012.06.008
  5. Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S., Naidu S.S., Nishimura R.A., Ommen S.R., Rakowski H., Seidman C.E., Towbin J.A., Udelson J.E., Yancy C.W. 2011 ACCF /AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):2761-2796. PMID: 22068435. https://doi.org/10.1161/CIR.0b013e318223e230
  6. Authors/Task Force members, Elliott P.M., Anastasakis A., Borger M.A., Borggrefe M., Cecchi F., Charron P., Hagege A.A., Lafont A., Limongelli G., Mahrholdt H., McKenna W.J., Mogensen J., Nihoyannopoulos P., Nistri S., Pieper P.G., Pieske B., Rapezzi C., Rutten F.H., Tillmanns C., Watkins H. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733-2779. PMID: 25173338. https://doi.org/10.1093/eurheartj/ehu284
  7. Bogachev-Prokophiev A., Afanasyev A., Zheleznev S., Fomenko M., Sharifulin R., Kretov E., Karaskov A. Mitral valve repair or replacement in hypertrophic obstructive cardiomyopathy: a prospective randomized study. Interact Cardiovasc Thorac Surg. 2017;25(3):356-362. PMID: 28575282. https://doi.org/10.1093/icvts/ivx152
  8. Obadia J.F., Basillais N., Armoiry X., Grinberg D., Dondas A., Barthelet M., Derimay F., Rioufol G., Finet G., Pozzi M. Hypertrophic cardiomyopathy: the edge-to-edge secures the correction of the systolic anterior motion. Eur J Cardiothorac Surg. 2017;51(4):638-643. PMID: 28007871. https://doi.org/10.1093/ejcts/ezw385
  9. Sado D.M., Flett A.S., McGregor C.G.A., Pantazis A.A., Elliot P.M., Moon J.C. Myectomy plus Alfieri technique for outflow tract obstruction in hypertrophic cardiomyopathy. Circulation. 2010;122(9):938-939. PMID: 20805440. https://doi.org/10.1161/CIRCULATIONAHA.110.969451
  10. Shah A.A., Glower D.D., Gaca J.G. Trans-aortic Alfieri stitch at the time of septal myectomy for hypertrophic obstructive cardiomyopathy. J Card Surg. 2016;31(8):503-506. PMID: 27401021. https://doi.org/10.1111/jocs.12804
  11. Tsutsumi Y., Numata S., Seo H., Ohashi H. Transaortic edge-to-edge mitral valve repair and left ventricular myectomy. Gen Thorac Cardiovasc Surg. 2013;61(4):223-225. PMID: 22851405. https://doi.org/10.1007/s11748-012-0131-2
  12. Collis R., Watkinson O., Pantazis A., Tome-Esteban M., Elliott P.M., McGregor C.G.A. Early and medium-term outcomes of Alfieri mitral valve repair in the management of systolic anterior motion during septal myectomy. J Card Surg. 2017;32(11):686-690. PMID: 29168204. https://doi.org/10.1111/jocs.13239
  13. Lapenna E., Nisi T., Ruggeri S., Trumello C., Del Forno B., Schiavi D., Meneghin R., Castiglioni A., Alfieri O., De Bonis M. Edge-to-edge mitral repair associated with septal myectomy in hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 2020;110(3):783-789. PMID: 32389564. https://doi.org/10.1016/j.athoracsur.2020.03.095
  14. Rowin E.J., Maron B.J., Chokshi A., Kannappan M., Arkun K., Wang W., Rastegar H., Maron M.S. Clinical spectrum and management implications of left ventricular outflow obstruction with mild ventricular septal thickness in hypertrophic cardiomyopathy. Am J Cardiol. 2018;122(8):1409-1420. PMID: 30107902. https://doi.org/10.1016/j.amjcard.2018.06.055
  15. Holst K.A., Hanson K.T., Ommen S.R., Nishimura R.A., Habermann E.B., Schaff H.V. Septal myectomy in hypertrophic cardiomyopathy: National outcomes of concomitant mitral surgery. Mayo Clin Proc. 2019;94(1):66-73. PMID: 30611455. https://doi.org/10.1016/j.mayocp.2018.07.022
  16. Hong J.H., Schaff H.V., Nishimura R.A., Abel M.D., Dearani J.A., Li Zh., Ommen S.R. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol. 2016;68(14):1497-1504. PMID: 27687190. https://doi.org/10.1016/j.jacc.2016.07.735
  17. Hodges K., Rivas C.G., Aguilera J., Borden R., Alashi A., Blackstone E.H., Desai M.Y., Smedira N.G. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg. 2019;157(6):2289-2299. PMID: 30782406. https://doi.org/10.1016/j.jtcvs.2018.11.148
  18. Sherrid M.V., Balaram S., Kim B., Axel L., Swistel D.G. The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context. J Am Coll Cardiol. 2016;67(15):1846-1858. PMID: 27081025. https://doi.org/10.1016/j.jacc.2016.01.071
  19. Patel P., Dhillon A., Popovic Z.B., Smedira N.G., Rizzo J., Thamilarasam M., Agler D., Lytle B.W., Lever H.M., Desai M.Y. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography. Circ Cardiovasc Imaging. 2015;8(7):e003132. PMID: 26082555. https://doi.org/10.1161/CIRCIMAGING.115.003132
  20. Afanasyev A., Bogachev-Prokophiev A., Lenko E., Sharifulin R., Ovcharov M., Kozmin D., Karaskov A. Myectomy with mitral valve repair versus replacement in adult patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2019;28(3):465-472. PMID: 30184144. https://doi.org/10.1093/icvts/ivy269
  21. Vassileva C.M., Boley T., Markwell S., Hazelrigg S. Mitral valve repair is underused in patients with hypertrophic obstructive cardiomyopathy. Heart Surg Forum. 2011;14(6):E376-E379. PMID: 22167765. https://doi.org/10.1532/HSF98.20111067
  22. Fucci C., Sandrelli L., Pardini A., Torracca L., Ferrari M., Alfieri O. Improved results with mitral valve repair using new surgical techniques. Eur J Cardiothorac Surg. 1995;9(11):621-627. PMID: 8751250. https://doi.org/10.1016/s1010-7940(05)80107-1
  23. Alfieri O., Maisano F., De Bonis M., Stefano P.L., Torracca L., Oppizzi M., La Canna G. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122(4):674-681. PMID: 11581597. https://doi.org/10.1067/mtc.2001.117277
  24. Alfieri O., Maisano F., De Bonis M. The edge-to-edge repair. MMCTS. 2005(0809).
  25. Bhudia S.K., McCarthy P.M., Smerdira N.G., Lam B.-K., Rajeswaran J., Blackstone E.H. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg. 2004;77(5):1598-1606. PMID: 15111150. https://doi.org/10.1016/j.athoracsur.2003.09.090
  26. Basaran M., Selimoglu O., Yildirim T., Temucin Ogus N. Use of Alfieri stitch technique in a patient with hypertrophic obstructive cardiomyopathy. Interact Cardiovasc Thorac Surg. 2006;5(6):738-739. PMID: 17670698. https://doi.org/10.1510/icvts.2006.137588